Novo Nordisk  

Kidney Damage

Detection and surveillance

Detection and surveillance of kidney problems and blood pressure are a routine part of Annual Review
Check for proteinuria yearly using reagent strips

Measure
urinary albumin excretion yearly ( if not proteinuric ) using :

pre-breakfast albumin:creatinine ratio, or

pre-breakfast urinary albumin concentration

if ratio >2.5 mg/mmol ( >30 mg/g ) in men or >3.5 mg/mmol ( >40 mg/g ) in women or concentration >20 mg/l :
  • Repeat to confirm
  • Monitor progression of kidney damage by more frequent measurement

Check for infection and consider other renal disease if proteinuria positive

exclude infection with leucocyte strips and mid-stream urine microscopy / culture

Measure serum creatinine yearly ( more often if abnormal )

Measure
blood pressure yearly for surveillance purposes ( sitting, 1st/5th sounds, 5 min rest )
Blood pressure management if raised albumin excretion rate
Treat aggressively with a target of <130/80 mmHg or lower if easily attained

stop smoking

reduce salt intake

reduce protein intake with target of <0.8 g/kg
use ACE inhibitors as first-line drug therapy
add loop diuretics, a-blockers, other agents if necessary
avoid the combination of ß-blockers and thiazides if dyslipidaemia
Other management
Maintain good blood glucose control and tight arterial risk factor control ( see above )
Treat urinary infections aggressively; consider papillary necrosis if recurrent
Arrange early evaluation by a nephrologist ( at creatinine <200-300 µmol/l ( <2.5-3.5 mg/dl ) )
No patient should be excluded from renal replacement programmes solely on the basis of having diabetes

 

Eye Damage

 

IDF Guidelines to Type 1 diabetes
Click here for 'Topic Finder'

Click here for 'Ensure effective delivery of care'
Click here for 'Promote effective self-care'
Click here for 'Control blood glucose, blood lipids, arterial factors'
Detect and manage diabetes complications
Kidney Damage
Eye Damage
Foot Problems
Nerve Damage
Click here for 'Manage special problems'
Click here for 'Index'



Novo Nordisk Click here to return to the top of the page